BIO CEO Jim Greenwood won’t admit last month’s midterm elections spell trouble for the drug industry.
{iframe}https://www.statnews.com/2018/12/03/the-new-congress-is-already-threatening-to-push-forward-on-drug-pricing-but-bio-ceo-jim-greenwood-isnt-changing-tack/{/iframe}